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ABSTRACT
Lansoprazole (LNS) and omeprazole (OMP) are therapeutically important drugs, and the need arose for a simple, reliable
method for their content uniformity of their tablets. The anodic polarographic behavior of lansoprazole and omeprazole has been
studied in Britton-Robinson buffer (BRb) over the pH range 4.1-11.5. In BRb of pH 7 well-defined anodic waves were produced
with diffusion-current constant (Id) of 1.70 ± 0.01 (n = 6) and 1.66 ± 0.01 (n = 8) for LNS and OMP, respectively. The current-concentration plots were rectilinear over the ranges of 4-24, 2-16 µg mL -1 using Direct Current (DCt) mode for LNS and OMP, respectively and over the range 2-18, 0.4-12 µg mL -1 using the Differential Pulse Polarographic (DPP) mode for LNS and OMP, respectively. The detection limits (S/N = 2) using DPP mode were 0.2 µg mL -1 (5.41 × 10-7 M) and of 0.05 µg mL -1 (1.45 × 10-7 M) for
LNS and OMP, respectively. The proposed method was successfully applied to the analysis of the two drugs in their commercial
capsules. The average percent recoveries were favorably compared to those obtained by reference methods, with satisfactory
standard deviations. A pathway for the electrode reaction in both cases was postulated. The proposed method is characterized by
being simple, accurate and stability-indicating.
Key words: lansoprazole, omeprazole, dosage forms, polarography, anodic current mode

INTRODUCTION

N
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Lansoprazole 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)2-pyridinyl]methyl]sulphinyl]-1 H-benzimidazole, is a new
proton-pump inhibitor with action and uses similar to those
of omeprazole. Lansoprazole has been demonstrated to be
effective in the treatment of duodenal and gastric ulcers,
where inhibition of gastric acid secretion may be beneficial (1).
Relatively few methods have been described for the
quantitative determination of lansoprazole in formulations
and biological fluids, viz., spectrophotometry(2,3), capillary
electrophoresis(4) and HPLC(5-12). A cathodic polarographic method has been described for the determination of lansoprazole in capsules and spiked urine(13). The method is
not stability-indicating as it is subject to interference by
degradation products. In the anodic mode of polarography,
the analytes are less subject to interference likely to be
introduced by common excipients, decomposition products
and related compounds.
As for omeprazole, 5-Methoxy-2-{[(4-methoxy-3,5dimethyl-2-pyridinyl)methyl]sulfinyl}-1H-benzimidazole, it
is a benzimidazole derivative which inhibits gastric acid
secretion. It acts by interaction with H+ K+ ATpase in the
secretory membranes of the parietal cells and is very effective in the treatment of Zollinger Ellison Syndrome.
Although its elimination half-life from plasma is short
* Author for correspondence. Tel: ++966-1-4677348;
Fax: ++966-1-4676220; E-mail: ffbelal@yahoo.com
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Figure 1. Structural formulae of lansoprazole and omeprazole.

(reported to be about 0.5 to 3 hr), its duration of action with
regard to inhibition of acid secretion is much longer allowing
it to be used in single daily dose(1). Several methods have
been utilized for the quantitative estimation of OMP in pharmaceutical preparations and biological fluids, including:
spectrophotometry (14-17), capillary electrophoresis (18,19),
voltammetry(20-23), HPLC(24-28) and TLC(29).
Recently the electrochemical oxidations of lansoprazole
and omeprazole have been studied at a carbon paste electrode by cyclic and differential pulse voltammetry(30). The
linear range is 2 × 10-7 to 5 × 10-5 M with detection limits of
1 × 10-8 and 2.5 × 10-8 M for LNS and OMP, respectively.
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In this piece of work, the anodic oxidation of the
studied compounds at the Dropping Mercury Electrode
(DME) has been exploited for developing a simple and
reliable method for their determination in dosage forms.
The method is satisfactorily accurate and precise and is
comparable to reference methods. Its major advantage is its
stability-indicating nature. The degradation of lansoprazole
and omeprazole is reported to produce the corresponding
sulphide(31). The latter is not readily oxidized at the DME,
therefore, the proposed method can be considered as a
stability-indicating assay for the two drugs.

MATERIALS AND METHODS
I. Apparatus
The polarographic study and Differential Pulse
Polarograhic (DPP) measurements were carried out using
the Polarecord E 506 Metrohm (Herisau, Switzerland). The
drop time of 1 sec was electronically controlled using a 663
VA Stand from the same company. The polarograms were
recorded using a potential scan rate of 10 mV/sec. A threeelectrode system composed of a dropping mercury
electrode (DME) as the working electrode, Ag˚/AgCl as
reference electrode, and a graphite rod as the auxiliary
electrode, was used. Polarograms were scanned between
-0.4 to +0.4 V vs Ag˚/AgCl electrode. The solutions were
purged with pure nitrogen gas for 5 min before being
polarographed at room temperature.
II. Materials and Reagents
(I) Lansoprazole and omeprazole were kindly provided by
Aventis Pharma, Cairo, Egypt and were used as received.
Lopral capsules each containing 30 mg of lansoprazole
(Batch. No. 010378) and Gasec capsules each containing
20 mg of omeprazole (Batch. No. 010097) were obtained
from commercial sources in the local market.
(II) Britton Robinson buffers (BRb) 0.08 M, covering the pH
range 4.1-11.5(32).
(III) Methanol: AR grade (Aldrich, USA).
(IV) Diethyl ether: AR grade (Aldrich, USA).
(V) Dichloromethane (BDH, Poole, England).

covering the working range (cited in table 2) into 25-mL volumetric flasks. Complete to the mark with BRb of pH 7.0.
Pass pure nitrogen gas for 5 min. Record the anodic DCt and
DPP polarograms over the range -0.4 to +0.4 V vs Ag˚/Ag Cl
reference electrode, using a pulse amplitude of 70 mV in case
of DPP mode. Plot the final concentration of the drugs (µg
mL-1) versus the current (µA) to get the calibration graph.
Alternatively, derive the corresponding regression equations.
IV. Procedure for Capsules
The contents of 10 capsules were mixed well and pulverized. A weighed quantity of the powder equivalent to
20 mg of the studied compounds was transferred into a
small flask and extracted with 3 × 30 mL of methanol. The
extract was filtered into a 100-mL volumetric flask. The
conical flask was washed with few mLs of methanol. The
washings were passed into the same conical flask and
completed to the mark with the same solvent. Aliquot
volumes covering the working concentration range were
transferred into 25-mL volumetric flasks. The volume was
completed with BRb of pH 7.0. The whole contents of the
flask were poured into the polarographic cell. Pure
nitrogen gas was passed for 5 min. The DC t and DPP
polarograms were recorded. The nominal content of the
capsules was calculated using either the calibration graph or
the corresponding regression equation.

RESULTS AND DISCUSSION
Figure 1 shows the typical polarograms of lansoprazole using both anodic (DCt and DPP) mode in BRb of pH
(B)

-0.4V

A

1.2 × 10-8A

(A)
B

(I) Standard solutions
Stock solutions containing 200 µg mL -1 of LNS and
OMP were prepared in methanol and were further diluted
with the same solvent to give the appropriate concentrations.
The solutions were stable for five days when kept in the
refrigerator. The methanol concentration in the polarographic cell was kept always at 20% of the total volume used.
III. Calibration Graph
Transfer aliquot volumes of the studied compounds

DCt

DPP
2 × 10-8A

160 mV

-0.4V

Figure 1. Typical polarograms of lansoprazole in BRb.
(A) DCt mode (24 µg mL -1); (B) DPP mode (24 µg mL -1).
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7. Omeprazole behaves similarly. Methanol (in a ratio of
20% v/v) is added as solubilizer for the drugs, meanwhile,
it decreases the adsorption phenomena likely to occur at the
surface of DME. Both the DCt and DPP peaks are sharp
pH 11.5

10.0

9.0

8.0

and steep and are therefore, suitable for quantitative determination of the drugs. Lansoprazole produces well-defined
anodic waves over the pH range of 4.1-11.5 in BRb (Figure
2). Omeprazole behaves similarly.

7.0

6.0

5.0

4.1

DCt
1.2 × 10-8A
160 mV

-0.4V

-0.4V

-0.4V

-0.4V

-0.4V

-0.4V

-0.4V

-0.4V

Figure 2. Effect of pH on the development of the polarographic waves of lansoprazole (20 µg mL -1) using the anodic DCt mode .
Table 1. Effect of pH on the development of the anodic polarographic waves of lansoprazole and omeprazole
Compound
pH
E1/2
E1/2/ pH
W1/2 (mV)*
Lansoprazole
4.1
+ 86
200
11
5.0
+ 76
230
12
6.0
+ 64
160
24
7.0
– 40
140
– 32
8.0
– 72
150
– 16
9.0
– 88
150
–8
10.0
– 96
160
– 48
11.5
– 144
150
Omeprazole
4.1
+ 56
broad
+ 44
5.0
– 16
160
– 96
6.0
– 112
170
– 42
7.0
– 154
140
– 30
8.0
– 184
190
– 16
9.0
– 200
140
0
10.5
– 200
180
0
11.2
–200
160
*W1/2: the half peak width (mV) in the DPP mode.
**α: the transfer coefficient.
***na: the number of electrons transferred in the rate determining step.
@?
@L
@1
?J@@L?
?7Y@1?
J5?3@L
?W.Y?V')X?hg
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αna**,***
0.45
0.47
0.59
0.70
0.53
0.51
0.46
0.46
0.70
0.622
0.78
0.93
0.86
0.70
0.59
0.55
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Logarithmic analysis of the oxidation waves of both
compounds obtained in BRb of different pH values resulted
in straight lines. The αna values were calculated according
to the treatment of Meites and Israel(33), at pH 7.0 the αna
values were found to be 0.70 and 0.93 for LNS and OMP
respectively (Table 1). Assuming that the rate-determining
step involves the transfer of two electrons, the values of the
slopes point out to the completely irreversible nature of the
electrode process.
I. Study of the Wave Characteristics
Increasing the mercury height (h) resulted in a corresponding increase in the waveheight (w) of both
—
compounds in the anodic mode; plots of √ h vs the waveheight gave straight lines. Plots of log h vs log w gave
straight lines, the slope of then were ~0.6. Changing the
buffer concentration over the range 0.006 - 0.06 M resulted
in a negligible decrease in the waveheight. These two characteristics point out to the diffusion-controlled nature of the
waves of both compounds.
The alternating current-behavior (ACt) of LNS was
studied as a model example using a phase-selective angle of
90˚ (Figure 3). In BRb of pH 7, the summit potential (Es)
was shifted to more negative value of 180 mV than the corresponding E 1/2 value. Figure 3 shows that at this pH
value, adsorption of the depolarizer only takes place while
the reduction product is not adsorbed. OMP was found to
behave similarly.
The studied compounds were found to be stable in

BRb of pH 7 (the analytical pH) for about one and half
hour at room temperature after which their waveheights
began to decrease slowly.
The diffusion-current constants (Id) were calculated at
room temperature (25C˚) according to Ilkovic equation(34)
for varying concentrations and were found to be 1.70 ± 0.01
(n = 6) and 1.66 ± 0.01 (n = 8) for LNS and OMP respectively, using the anodic DCt mode. The results are shown in
Table 4. The diffusion coefficients (D) were calculated using
different concentrations of the drugs and were found to be
1.97 × 10-6 cm2 sec-1 and 1.88 × 10-6 cm2 sec-1 for LNS and
OMP respectively. These small values may be attributed to
the bulky nature of the depolarizers.
II. Mechanism of the Electrode Reaction
The number of electrons involved in the electrode
reaction of both compounds was established via comparison
of the waveheight of lansoprazole with that obtained from
an equimolar solution of a previously studied compound
with equal diffusion coefficient; namely, nilvaldipine(35). In
BRb of pH 7.0, both compounds gave one wave of the
same height. It can be concluded therefore that, only the
sulphoxide group is involved in the anodic process being
oxidized into the corresponding sulphone group (Scheme
1). The following mechanism is postulated for the
electrode reaction:
H
N

O
S R + H2O

DME

N

H
N

O

N

O

S R + 2H++ 2e

Scheme 1.

III. Analytical Applications

8 × 10-8A

200 mV
SE

-0.4V

Figure 3. Alternating current behaviour of lansoprazole (20 µg mL -1)
in BRb of pH 7. Superimposed alternating voltage: 15 mV; frequency
75 Hz; phase angle 90˚. (SE: Supporting Electrolyte).

Figure 1 shows the typical anodic DC t and DPP
polarograms of lansoprazole in BRb of pH 7, respectively.
The current is proportional to the concentration of the depolarizers over a convenient range. Both DCt and DPP modes
in the anodic technique were successfully applied to the
assay of LNS and OMP whether per se or in dosage forms.
Plots representing the relationship between the concentration of the studied compounds and the diffusion current
give straight lines over the concentration range of 4-24, and
2-16 µg mL -1 using Direct Current (DCt) mode for LNS
and OMP, respectively and over the range 2-18 and 0.4-12
µg mL -1 using the Differential Pulse Polarographic (DPP)
mode for LNS and OMP respectively. The lower detection
limit (S/N = 2) were 0.2 µg mL -1 (5.41 × 10-7 M) and of
0.05 µg mL -1 (1.45 × 10-7 M) for LNS and OMP, respectively adopting the DPP technique (Table 2).
Linear regression analysis of the data gave the
following equations:
(I) For lansoprazole
id = 4.5 × 10-4 + 0.0055 C

(r = 0.9999, DCt mode)
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Table 2. Analytical parameters for the polarographic determination of lansoprazole and omeprazole using anodic DCt and DPP modes respectively
Parameter
Lansoprazole
Omeprazole
DCt mode
DPP mode
DCt mode
DPP mode
Concentration range (µg/mL)
4-24
2-18
2-16
0.4-12
Lower detection limit (M)
—
5.42 × 10-7
—
1.45 × 10-7
Correlation coefficient (r)
0.9999
0.9999
0.9999
0.9999
Slope
0.0055
0.0196
0.0058
0.031
1.536 × 10-3
1.621 × 10-4
3.593 × 10-4
Intercept
4.5 × 10-4
Sy/x*
2.048 × 10-4
1.43 × 10-3
3.503 × 10-4
1.117 × 10-3
**
-5
-3
-4
Sa
7.598 × 10
9.36 × 10
2.575 × 10
7.977 × 10-4
Sb***
1.224 × 10-5
9.60 × 10-5
2.703 × 10-5
8.907 × 10-5
****
% Error
0.13
0.33
0.27
0.24
*Sy/x: Standard deviation of residuals.
**Sa: Standard deviation of intercept of regression line.
***Sb: Standard deviation of slope of regression line.
––
****% Error: RSD% / √ n
Table 3. Polarographic analysis of lansoprazole and omeprazole in pure form using DCt and DPP modes respectively
Compound
DCt mode
DPP mode
Lansoprazole
No. of Experiments
6
7
Mean found (%) ± SD
99.96 ± 0.33
100.03 ± 0.88
Variance
0.11
0.77
Student’s t-value
0.91 (2.37)
0.34 (2.31)
Variance ratio F-test
2.42 (5.79)
2.76 (5.14)
Omeprazole
No. of Experiments
8
10
Mean found (%) ± SD
99.87 ± 0.76
99.58 ± 0.75
Variance
0.58
0.56
Student’s t-value
0.17 (2.26)
0.74 (2.20)
Variance ratio F-test
1.43 (4.74)
1.47 (4.26)
Figures in parentheses are the tabulated t and F values respectively at p = 0.05(36).

ip= 1.536 × 10-3 + 0.019 C

(r = 0.9999, DPP mode)

(II) For omeprazole
id = 1.621 × 10-4 + 0.0058 C (r = 0.9999, DCt mode)
ip = 3.593 × 10-4 + 0.031 C (r = 0.9999, DPP mode)
where C is the concentration in µg mL -1, id is the
diffusion current (in µA) in the DC t mode and ip is the
current in the DPP mode respectively.
Statistical evaluation of the regression lines regarding
the standard deviation of the residuals (Sy/x), the standard
deviation of the intercept (Sa) and standard deviation of the
slope (Sb) are also shown in Table 2. The small values of
the figures point out to the high precision of the proposed
method.
Statistical analysis of the results obtained by the
proposed and reference methods(3,14), using the Student’s ttest and Variance ratio F test, shows no significant difference between the performance of the two methods
regarding the accuracy and precision, respectively(36). The
results are shown in Table 3.
Each of DCt, DPP modes were successfully applied to
the determination of LNS and OMP in commercial capsules
(30 mg and 20 mg each) and the results obtained are
abridged in Table 5. Capsule excipients such as starch, talc
magnesium stearate, lactose, avisil and gelatin did not

Reference methods(3,14)
3
100.22 ± 0.53
0.28

3
99.96 ± 0.91
0.83

interfere with the assay.
As one of the possible pathways of degradation of these
compounds is the oxidation of the sulphoxide group into the
corresponding sulphone, the method can be therefore considered as stability-indicating assay for the two drugs.

CONCLUSION
A simple and fairly sensitive method was developed
for the determination of lansoprazole and omeprazole in
their capsules. The method has some distinct advantages
over other existing methods regarding simplicity and time
saving. The lower detection limits are 5.41 × 10-7 M and
1.45 × 10-7 M for LNS and OMP respectively using the
DPP modes which are comparable to those reported by
chromatographic methods(7). The concentration range and
the detection limit are comparable to those reported by
recently published voltammetric method(30). Moreover, the
method can be considered as a stability-indicating assay for
the two drugs.
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Table 4. Correlation between the concentration of lansoprazole, omeprazole and the diffusion current in the DCt mode
Compound
No.
Concentration (mM)
Current (µA)
id/C (µA/mM)
Lansoprazole
1
1.083 × 10-2
0.0225
2.077
0.0450
2.077
2
2.166 × 10-2
0.0667
2.054
3
3.249 × 10-2
0.0892
2.060
4
4.332 × 10-2
0.1110
2.049
5
5.415 × 10-2
0.1335
2.054
6
6.498 × 10-2
Mean
2.062
± SD
0.011
Omeprazole
1
5.79 × 10-3
0.0117
2.021
0.0231
1.995
2
1.158 × 10-2
0.0351
2.021
3
1.737 × 10-2
0.0468
2.021
4
2.316 × 10-2
0.0590
2.038
5
2.895 × 10-2
0.0700
2.015
6
3.474 × 10-2
0.0815
2.011
7
4.053 × 10-2
0.0928
2.005
8
4.632 × 10-2
Mean
2.016
± SD
0.013
Each result is the average of three separate determinations.

Table 5. Application of the proposed method to the analysis of the studied compounds in dosage forms
Pharmaceutical preparations
Recovery (%) of DCt mode
Recovery (%) of DPP mode
Lopral capsulesa
99.38
100.15
(30 mg of lansoprazole/
101.50
99.58
capsule)
99.73
101.26
101.32
101.48
102.02
101.63
Mean found (%) ± SD
100.93 ± 0.99
100.61 ± 0.79
t-value
1.02 (2.37)
0.59 (2.57)
F-value
1.26 (5.79)
2.03 (9.55)
98.75
98.80
Gasec capsulesb
(20 mg of omeprazole/
99.16
100.80
capsule)
99.66
99.60
99.75
101.00
100.46
99.57
99.09
Mean found (%) ± SD
99.48 ± 0.61
99.95 ± 0.92
t-value
2.10 (2.37)
0.89 (2.45)
F-value
3.76 (5.79)
1.64 (6.94)
Each result is the average of three separate determinations.
Figures in parentheses are the tabulated t and F values respectively at p = 0.05(36).
a
Product of T3A, Assiut, Egypt.
b
Product of Medical Union Pharmaceuticals Abu Sultan, Ismalia, Egypt.

Humboldt Foundation, Bonn, Germany, for kindly providing
the instrument used in this study, to his department.

REFERENCES
1. Parfitt, K. editor, Martindale, 1999. “The Complete
Drug Reference”. 32nd ed. pp. 1196, 1204. The
Pharmaceutical Press. Massachusetts, U. S. A.
2. Moustafa, A. A. M. 2000. Spectrophotometric method
for the determination of lansoprazole and pantoprazole
sodium sesquihydrate. J. Pharm. Biomed. Anal. 22 (1):
45-58.

Id = id/ C m 2/3 t1/6
1.714
1.714
1.695
1.699
1.691
1.695
1.702
0.009
1.667
1.646
1.667
1.667
1.682
1.663
1.659
1.654
1.663
0011

Reference methods(3,14)
101.56
98.83
100.19

100.19 ± 1.11

99.37
101.72
100.69

100.59 ± 1.18

3. Ozaltin, N. 1999. Determination of lansoprazole in
pharmaceutical dosage forms by two different spectroscopic methods. J. Pharm. Biomed. Anal. 20 (3): 599606.
4. Tivesten, A., Folestad, S., Schonbacher, V. and
Svensson, K. 1999. Non aqueous capillary electrophoresis for the analysis of labile pharmaceutical
compounds. Chromatographia 49 (I): S7-S11.
5. Ekpe, A. and Jacobsen, T. 1999. Effect of various salts
on the stability of lansoprazole, omeprazole and pantoprazole as determined by high-performance liquid chromatography. Drug Dev. Ind. Pharm. 25(9): 10571065.
6. Borner, K., Borner, E. and Lode, H. 1998. Separation of

108
Journal of Food and Drug Analysis, Vol. 12, No. 2, 2004

lansoprazole enantiomers in human serum by HPLC.
Chromatographia. 47 (3-4): 171-175.
7. Borner, K., Borner, E. and Lode, H. 1997. Quantitative
determination of lansoprazole in human serum by
HPLC. Chromatographia 45: 450-452.
8. Pandya, K. K., Mody V. D., Satia, M. C., Modi, I. A.
Modi, R. I., Chakravarthy, B. K. and Gandhi, T. P.
1997. High-performance thin-layer-chromatographic
method for the detection and determination of lansoprazole in human plasma and its use in pharmacokinetic
studies. J. Chromatogr. Biomed. Appl. 693(1): 199-204.
9. Li, Y. M., Chen, L. Y., Ma, L. J. and Zhang, Q. Y. 1996.
HPLC determination of lansoprazole in human plasma.
Yaowu- Fenxi -Zazhi 16(4): 252-254.
10. Karol, M. D., Granneman, G. R. and Alexander, K.
1995. Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 668 (1): 182-186.
11. Delhotal Landes, B., Miscoria, G. and Flouvat, B. 1992.
Determination of lansoprazole and its metabolites in
plasma by high-performance liquid chromatography
using a loop column. J. Chromatogr. Biomed. Appl.
577(1): 117-122.
12. Aoki, I., Okumura, M. and Yashiki, T. 1991. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and
urine. J. Chromatogr. Biomed. Appl. 571(1-2): 283-290.
13. El-Zehouri, J. and Madi, S. 2001. Polarographic method
for the determination of lansoprazole in dosage form
and spiked human urine. Saudi. Pharm. J. 9: 99.
14. Ozaltin, N. and Kocer, A. 1997. Determination of
omeprazole in pharmaceuticals by derivative spectroscopy. J. Pharm. Biomed. Anal. 16(2): 337-342.
15. Sastry, C. S. P., Naidu, P. Y. and Murty, S. S. N. 1997.
Spectrophotometric methods for the determination of
omeprazole in bulk form and pharmaceutical formulations. Talanta 44 (7): 1211-1217.
16. Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and
Agbaba, D. 2003. First order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole
sodium salt and corresponding impurities. J. Pharm.
Biomed. Anal. 32 (4-5): 1019-1027.
17. Salama, F., El-Abasawy, N., Abdel Razeq, S. A., Ismail,
M. M. F. and Fouad, M. M. 2003. Validation of spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. (In Press).
18. Altria, K. D., Bryant, S. M. and Hadgett, T. A. 1997.
Validation of capillary electrophoresis method for the
analysis of a range of acidic drugs and excipients. J.
Pharm. Biomed. Anal. 15(8): 1091-1101.
19. Eberle, D., Hummel, R. P. and Kuhn, R. 1997. Chiral
resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin
in capillary electrophoresis. J. Chromatogr. 759 (12):
185-192.
20. Pinzauti, S., Gratteri, P., Furlanetto, S., Mura, P.,
Dreassi, E. and Phan-Tan-Luu, R. 1996. Experimental

design in the development of voltammetric method for
the assay of omeprazole. J. Pharm. Biomed. Anal. 14
(8-10): 881-889.
21. Ozaltin, N. and Temizer, A. 1994. Differential-pulsepolarographic determination of omeprazole in pharmaceutical preparations. Electroanalysis 6 (9): 799-803.
22. Mcclean, S., Okane, E., Ramachandran, V. N. and
Smyth, W. F. 1994. Differential-pulse-polarographic
study of the degradation of hydrogen ion/potassium ion
ATPase inhibitors skandF 95601 and omeprazole in
acidic media and the subsequent reaction with thiols.
Anal. Chim. Acta. 292 (1): 81-89.
23. Oelschlaeger, H. and Knoth, H. 1998. Polarographic
analysis of omeprazole formulations. Pharmazie 53 (4):
242-244.
24. Yeung, P. K. F., Little, R., Jiang, Y., Buckley, S. J. Pollak,
P. T., Kapoor, H. and Veldhuyzen-van-zanten, S. J. O.
1998. A simple high-performance liquid chromatography assay for simultaneous determination of omeprazole
and metronidazole in human plasma and gastric fluids. J.
Pharm. Biomed. Anal. 17 (8): 1393-1398.
25. Xu, X. P., Dai, C. Z. and Li, T. 1997. Studies on chromatographic optimization and its application in pharmacokinetics research. Fenxi. Ceshi. Xuebao. 16 (2): 48-53.
26. Gangadhar, S., Kumar, G. S. R. and Rao, M. N. V. S.
1997. Reverse phase high-performance liquid chromatography assay of omeprazole in plasma. Indian
Drugs 34 (2): 99-101.
27. Macek, J., Ptacek, P. and Klima, J. 1997. Determination
of omeprazole in human plasma by high-performance
liquid chromatography. J. Chromatogr. B 689 (1): 239243.
28. Katsuki, H., Hamada, A., Nakamura, C., Arimori, K.
and Nakano, M. 2001. High-performance liquid chromatographic assay for the simultaneous determination
of lansoprazole enantiomers and metabolites in human
liver microsomes. J. Chromatogr. Biomed. Appl.
757(1): 127-133.
29. Dogrukol, A. K. D., Tunalier, Z. and Tuncel, M. 1998.
TLC densitometric determination of omeprazole in pharmaceutical preparations. Pharmazie 53 (4): 272-273.
30. Radi, A. 2003. Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode. J.
Pharm. Biomed. Anal. 31 (5): 1007-1012.
31. McClean, S., Okane, E., Ramachandran, V. N. and
Smyth, W. F. 1994. Differential pulse polarographic
study of the degradation of H+/K+ ATPase inhibitor
SK&F 95601 and omeprazole in acidic media and the
subsequent reaction with thiols. Anal. Chim. Acta. 292:
81-89.
32. Heyrovsky, J. and Zuman, P. 1968. “Practical
Polarography”. pp. 163, 179. Academic Press. New
York, U. S. A.
33. Meites, L. and Israel, Y. 1961. The calculation of electrochemical kinetic parameters from polarographic
current potential curves. J. Am. Chem. Soc. 83: 4903.
34. Heyrovsky, J. and Kuta, J. 1965. Principles of

109
Journal of Food and Drug Analysis, Vol. 12, No. 2, 2004

Polarography Czechoslovak. p. 82 Academy of Science.
Prague.
35. Belal, F., Abdine, H. and Zoman, N. 2002. Anodic
polarographic determination of nilvadipine in dosage
forms and spiked human urine. Mikrochim. Acta. 140:
21-27.

36. Caulcut, R. and Boddy, R. 1983. Statistics for
Analytical Chemists Chapman and Hall. London, U. K.

